Hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Constitutive IL7R (C7R) Modified Banked Allogeneic CD30.CAR EBVSTS for CD30-Positive Lymphomas [Phase 1]
Phase 1 clinical trial update for constitutive IL7R (C7R) modified banked allogeneic CD30.CAR EBVSTs in CD30-positive lymphomas, currently r…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell Lymphoma [Phase 1]
A Phase 1 clinical trial is evaluating the combination of nivolumab with ASTX727 (decitabine/cedazuridine) in relapsed or refractory B-cell …
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Survey of Brentuximab Vedotin in Pediatric Participants With Hodgkin Lymphoma
An ongoing clinical trial update evaluating brentuximab vedotin in pediatric participants with Hodgkin lymphoma, currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: An Engineered Sirpα Fused to Anti-Pd-L1 And Tgf-β Fusion Protein (HCB301) in Subjects With Selected Advanced Tumors [Phase 1]
A Phase 1 clinical trial evaluating HCB301, an engineered Sirpα fusion with anti-PD-L1 and TGF-β activity, in patients with selected advance…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Interrupting Sedentary Time to Improve Cardiometabolic Health and Toxicity in Patients With Lymphoma Receiving Chemotherapy: The iSTAND Trial [NA]
Clinical trial evaluating whether interrupting sedentary time can improve cardiometabolic health and chemotherapy-related toxicity in patien…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen
Prospective collection, storage, and reporting of data on patients undergoing hematopoietic stem cell transplantation using a standard prepa…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
A multicenter protocol to improve access and distribution of unlicensed cryopreserved cord blood units, with the study currently recruiting.…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Anti-CD30 biAb-AATC in Patients With Relapsed/Refractory CD30 Positive Hematopoietic Malignancies [Phase 1]
Phase 1 trial evaluating an anti-CD30 bispecific antibody (AATC) in relapsed/refractory CD30-positive hematologic malignancies; currently re…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Evaluating the Impact of Social and Genetic Factors on Outcomes in Adolescent and Young Adult Cancer Survivors
A multicenter clinical trial is evaluating how social and genetic factors influence outcomes among adolescent and young adult survivors of H…
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: Comparison of AVD + Low-Dose Nivolumab vs. PET-Adapted BEACOPP-like in Advanced cHL [Phase 2]
An ongoing Phase 2 trial comparing AVD with low-dose nivolumab versus PET-adapted BEACOPP-like therapy in advanced classical Hodgkin lymphom…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Brentuximab Vedotin in Early Stage Hodgkin Lymphoma [Phase 3]
A Phase 3 clinical trial evaluating Brentuximab vedotin in early-stage Hodgkin lymphoma is currently recruiting. The sponsor listed is Unive…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: A Study of Carmustine With and Without Ethanol in Subjects With Lymphoma [Phase 2]
A Phase 2 clinical trial evaluating carmustine with and without ethanol in subjects with lymphoma, including Hodgkin and non-Hodgkin lymphom…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant [Phase 1]
Phase 1 clinical trial evaluating CMV-MVA Triplex Vaccine to enhance CMV-specific immunity and prevent CMV viremia in patients undergoing ha…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Improving Exercise Capacity With a Tailored Physical Activity Intervention [NA]
This clinical trial update indicates Wake Forest University Health Sciences is recruiting for a tailored physical activity intervention aime…
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: CCCG-HD-2018 for Children and Adolescents With Newly Diagnosed Hodgkin Lymphoma [Phase 4]
Phase 4 clinical trial CCCG-HD-2018 for newly diagnosed Hodgkin lymphoma in children and adolescents. The study is currently active but not …
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: ctDNA-Guided Therapy for Relapsed/Refractory Hodgkin Lymphoma [Phase 2]
A Phase 2 clinical trial evaluating ctDNA-guided therapy for adults with relapsed or refractory Hodgkin lymphoma; the study is currently not…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051) [Phase 1, Phase 2]
A pediatric Phase 1/2 study of pembrolizumab (Keytruda) in children with advanced solid tumors or lymphoma is currently recruiting. The tria…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: A Phase II Trial of Mosunetuzumab, Polatuzumab, Tafasitamab, and Lenalidomide in Patients With Relapsed B-cell NHL [Phase 2]
A Phase II trial is evaluating a four-drug combination (mosunetuzumab, polatuzumab vedotin, tafasitamab, and lenalidomide) in relapsed B-cel…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders [Phase 2]
Phase 2 clinical trial evaluating cord blood transplant in children and young adults with blood cancers and select non-malignant disorders; …
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant [Phase 2]
Phase 2 clinical trial evaluating CMV-MVA Triplex vaccination in HLA-matched related stem cell donors to prevent cytomegalovirus infection i…
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: Nivolumab With Ruxolitinib in Relapsed or Refractory Classical Hodgkin Lymphoma [Phase 1, Phase 2]
An ongoing phase 1/2 clinical trial is evaluating the combination of nivolumab and ruxolitinib for relapsed or refractory classical Hodgkin …
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: A Study of Melphalan in People With Lymphoma Getting an Autologous Hematopoietic Cell Transplant [Phase 1]
A Phase 1 study evaluating the use of melphalan in lymphoma patients undergoing autologous hematopoietic cell transplantation.
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: Tislelizumab, Gemcitabine and Cisplatin for R/R Hodgkin Lymphoma Followed by Tislelizumab Consolidation in Patients in Metabolic Complete Remission [Phase 2]
Phase 2 clinical trial of tislelizumab with gemcitabine and cisplatin for relapsed/refractory Hodgkin lymphoma, followed by tislelizumab con…
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: Evaluation of Chemotherapy-induced Cognitive Disorders During the Treatment of Hematological Malignancies
A clinical trial update notes a study evaluating chemotherapy-induced cognitive disorders in patients treated for hematological malignancies…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Personalized Reduction of Chemotherapy Intensity Through ctDNA Evaluation for the Treatment of Patients With Advanced Hodgkin Lymphoma [Phase 2]
Phase 2 clinical trial investigating personalized reduction of chemotherapy intensity in advanced Hodgkin lymphoma guided by ctDNA measureme…